Radiology’s first app received U.S. FDA approval in February 2011. More will be coming.
By Whitney L.J. Howell
Radiology’s first app received U.S. Food and Drugs Administration (FDA) approval in February 2011. Called Mobile MIM, it lets radiologists review images and make diagnoses. Others, such as Mobile AbbaDox, let you review and sign off on reports, listen to dictation, and sift through your workflow.
“This important mobile technology provides physicians with the ability to immediately view images and make diagnoses without having to be back at the workstation or wait for film,” said William Maisel, M.D., MPH, chief scientist and deputy director for science in the FDA’s Center for Devices and Radiological Health, in a written statement.
The agency also plans to issue draft guidance for mobile applications manufacturers to provide clarity for developing future health care products.
In other words, this was the first of many apps to come.
The apps offer several benefits, said Asim Choudhri, M.D., a neuroradiologist at Le Bonheur Children’s Hospital in Memphis, although he doesn’t recommend using them for final diagnoses. Many radiologists use them to consult from anywhere at any time. Others bring surgeons into the patient-care conversation to determine whether a patient needs surgery. The apps also promote multidisciplinary treatment decisions, such as those for stroke patients, because providers see the same information simultaneously.
Choudhri published a study in 2009 through the Radiological Society of North America detailing how well radiologists could make diagnoses with mobile devices. Most mobile devices offer screen resolutions comparable to those found in workstations, he said.
According to research completed in April by DiagnosticImaging.com, 52 percent of U.S. physicians currently own an iPhone and another 25 percent plan on owning one in the next 12 months. In a year, about 60 percent of physicians will have an iPad.
Be aware – apps have downsides. Instant access means access at 2 a.m., even when you aren’t on call. Looking at images on a mobile device gives you a good sense of the patient’s condition, but it is possible to miss the minute problems.
Despite diagnostic app limitations, Elliot Fishman, M.D., professor of radiology, surgery, and oncology at Baltimore’s Johns Hopkins, said this technology is radiology’s future.
“This isn’t going to be a unique thing. This is where radiology is going to go,” said Fishman who has created multiple radiology apps and used one clinically for the past six months. “Apps will impact everything from education to patient care in a positive way.”
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.